Clinical Trial Update: Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating budesonide for efficacy and safety in oral chronic graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Oral Chronic Graft vs Host Disease | Phase 3 | Status: COMPLETED